China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2011-12-31 01:30 China Supports Foreign Direct Investment in Biotechnology 2011-12-30 01:30 Harbin Pharma Trades $870 Million of Stock for Assets from Parent 2011-12-29 01:30 China Health Resource, a TCM Maker, Ready to Start M&A Hunt 2011-12-28 01:30 Yunnan Baiyao Opens New Production Facility 2011-12-27 01:30 China Events at the J.P. Morgan Healthcare Conference 2011-12-25 01:30 The Week in Review: Hutchison MediPharma and AstraZeneca Partner on Cancer Drug 2011-12-24 01:30 Frontage Labs Opens Clinical-Stage CRO in Jilin Hospital and more... 2011-12-23 01:30 Sanjiu Expected to Acquire Guangdong Pharma through Auction 2011-12-22 01:30 Hutchison MediPharma Inks $140 Million Cancer Deal with AstraZeneca and more... 2011-12-21 01:30 Hua Medicine In-licenses Diabetes Drug Candidate from Roche and more... 2011-12-20 01:30 Beijing SL Pharma Forms US-based Diabetes JV and more... 2011-12-18 01:30 The Week in Review: Simcere and BMS Add Cardiovascular Drug to Partnership 2011-12-17 01:30 China Sky One Partners Up to Form New Stem Cell Company 2011-12-16 01:30 Boehringer Ingelheim Sets $91 Million Shanghai Expansion and more... 2011-12-15 01:30 Simcere and Bristol-Myers Squibb Partner on Cardiovascular Drug and more... 2011-12-14 01:30 Quintiles, a Clinical-Stage CRO, will Double China Headcount and more... 2011-12-13 01:30 Pfizer's Dual R&D Strategy for China and more... 2011-12-11 01:30 The Week in Review: Merck Plans Beijing R&D Center; $1.5 Billion China Investment 2011-12-10 01:30 Beijing SL Pharma Buys Stake in Forwell Biopharm and more... 2011-12-09 01:30 AstraZeneca Buys China Generic Drug Firm; Announces US Layoffs 2011-12-08 01:30 Conba Buys 84% of Yunnan Xiogye Pharma and more... 2011-12-07 01:30 Merck Will Build Beijing R&D Center; Invest $1.5 Billion in China 2011-12-06 01:30 Foci Pharma to IPO in Shenzhen and more... 2011-12-04 01:30 The Week in Review: China's 12th Five-year Plan for Medical Technology 2011-12-03 01:30 China's 12th Five-year Plan for Medical Technology and more... 2011-12-02 01:30 WHO Certification a Shot-in-the-Arm for China Vaccine Makers and more... 2011-12-01 01:30 Ascletis Nominated for Financing Deal of the Year   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC